Aroa Biosurgery Limited (ASX: ARX)
Australia
· Delayed Price · Currency is AUD 0.720
+0.020 (2.86%)
Dec 4, 2024, 4:10 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 241.43 million as of December 3, 2024. Its market cap has increased by 4.92% in one year.
Market Cap
241.43M
Enterprise Value
227.65M
Revenue
70.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.72
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 241.43M, a decrease of -40.40%. That is a compound annual growth rate of -11.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2024 | 241.43M | -15.30% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | 345.84M | -14.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 137.81B |
| ResMed Inc. | 55.66B |
| Pro Medicus Limited | 26.83B |
| Fisher & Paykel Healthcare Corporation Limited | 20.52B |
| Cochlear Limited | 19.95B |
| Sonic Healthcare Limited | 13.81B |
| Ramsay Health Care Limited | 9.34B |
| Telix Pharmaceuticals Limited | 8.27B |